U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838129) titled 'Evaluation of Corneal Endothelium Health Following Articaine Ophthalmic Solution Administration' on Sept. 18.
Brief Summary: The goal of this clinical trial is to evaluate the corneal endothelium health of eyes treated with articaine ophthalmic solution in adult participants.
Study Start Date: Jan., 2027
Study Type: INTERVENTIONAL
Condition:
Healthy Cornea
Intervention:
DRUG: Articaine (CYKLX)
Two drops of Articaine administered sequentially to the study eye.
DRUG: Vehicle
Two drops of Vehicle administered sequentially to the study eye.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Laboratoires Thea
Published by HT Di...